Accueil・Liste d'Actions・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Ouvert

SecteurSoins de santé

95.59 -0.94

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

94.16

Max

96.98

Chiffres clés
By Trading Economics
Revenu	99M 239M
Ventes	-157M 2.1B
P/E Moyenne du Secteur	23.852 64.641
BPA	2.09
Rendement du dividende	1.05
Marge bénéficiaire	11.43
Employés	17,000
EBITDA	84M 538M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+2.66% upside

Dividendes
By Acuity
Rendement du dividende Moyenne du Secteur	1.05% 2.31%
Prochains Résultats	5 août 2026
Date du Prochain Dividende	30 oct. 2026
Date du Prochain Détachement de Dividende	29 sept. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-110M 18B
Ouverture précédente	96.53
Clôture précédente	95.59

Sentiment de l'Actualité

By Acuity

31%

69%

97 / 340 Classement par Healthcare

Zimmer Biomet Holdings Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 août 2026, 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31 juil. 2026, 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30 juil. 2026, 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29 juil. 2026, 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28 juil. 2026, 20:03 UTC

News

Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27 juil. 2026, 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24 juil. 2026, 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23 juil. 2026, 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22 juil. 2026, 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20 juil. 2026, 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Comparaison

Variation de prix

Zimmer Biomet Holdings Inc prévision

Objectif de Prix

By TipRanks

2.66% hausse

Prévisions sur 12 Mois

Moyen 99.56 USD 2.66%

Haut 115 USD

Bas 83 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

10 ratings

Achat

Maintien

Vente

Basé sur 10 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

97 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.